Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by scaleyon May 24, 2020 6:17pm

231 Views

Post# 31067063

This week

Greetings folks. I'll start with saying that the bashing has become pathetic. So that's a good sign. The Basher has been saying the same verbal diarrhea for a few years. But now it's just stupidity. A very unhinged wierdo. Geez. Seriously-If are thinking about buying- do it! Expect the next few weeks to be interesting( to say the least) . The next news ( hopefully/probably Monday-Tuesday) will tie into the Salzman purchase news. Then expect another 2 news releases within a few weeks. Have a great week everyone ( you included penny) . The time has arrived for kaly, in a big way. Cha Ching folks

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?